Literature DB >> 22333523

Hypogonadism due to hyperprolactinemia and subsequent first episode of psychosis.

Evdoxia Tsigkaropoulou1, Melpomeni Peppa, Christina Zompola, Emmanouil Rizos, Ioanna Xelioti, Sofia Chatziioannou, Anastasia Filippopoulou, Lefteris Lykouras.   

Abstract

BACKGROUND: Hyperprolactinemia causes hypogonadotrophic hypogonadism. Hyperprolactinemia can be pre-existing in some patients with schizophrenia. Dopamine is the most important prolactin-inhibiting factor, and dopaminergic hyperactivity has been implicated in the pathophysiology of psychosis.
OBJECTIVE: Since dopamine is a prolactin-inhibiting factor and dopamine imbalanced has been implicated in the pathophysiology of psychotic disorders, we investigated the probable relationship between hyperprolactinemia and the development of psychotic symptoms, in a patient with hypogonadism due to hyperprolactnemia and subsequent first episode of psychosis. Since dopamine is a prolactin-inhibiting factor and dopamine imbalance has been implicated in the pathophysiology of psychotic disorders, we investigated the probable relationship between hyperprolactinemia and the development of psychotic symptoms.
METHODS: We present the case of a patient with hypogonadism secondary to chronic, untreated hyperprolactinemia who developed acute psychotic symptoms.
RESULTS: Psychotic symptoms resolved soon after treatment with aripiprazole in conjunction with cabergoline, with a concomitant decrease in serum prolactin level.
CONCLUSION: This is an interesting case illustrating a complicated relationship among hypogonadism secondary to a prolactinoma and dopamine and psychosis.
Copyright © 2012 Elsevier HS Journals, Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22333523     DOI: 10.1016/j.genm.2012.01.001

Source DB:  PubMed          Journal:  Gend Med        ISSN: 1550-8579


  2 in total

1.  Acute psychosis as a presentation of hypopituitarism.

Authors:  Shruti Kate; Dinesh Kumar Dhanwal; Shishir Kumar; Praveen Bharti
Journal:  BMJ Case Rep       Date:  2013-07-13

Review 2.  The effects of novel and newly approved antipsychotics on serum prolactin levels: a comprehensive review.

Authors:  J Peuskens; L Pani; J Detraux; M De Hert
Journal:  CNS Drugs       Date:  2014-05       Impact factor: 5.749

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.